Lei Wei
Impact in
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
-
- Traditional Chinese Medicine Analysis
Papers in
-
- Cancer therapeutics and mechanisms 3
- Natural product bioactivities and synthesis 3
-
- Postharvest Quality and Shelf Life Management 3
- Co-authors
- Min Jiang (6 shared papers)Gang Bai (5 shared papers)Gabrielle Williams (1 shared paper)Jonathan C. Craig (1 shared paper)Anna Lee (1 shared paper)Han Zhang (6 shared papers)Yaya Cui (1 shared paper)Guoqiao Jiang (1 shared paper)
- Journals
- Biomedicine & Pharmacotherapy (5 papers)Frontiers in Pharmacology (4 papers)Postharvest Biology and Technology (3 papers)Journal of Medicinal Chemistry (2 papers)The FASEB Journal (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Lei Wei
53 papers receiving 775 citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Pharmaceutical Science 91
- Complementary and alternative medicine 96
- Urology 42
- Pharmacology 56
- Dermatology 51
Countries citing papers authored by Lei Wei
This map shows the geographic impact of Lei Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Wei more than expected).
Fields of papers citing papers by Lei Wei
This network shows the impact of papers produced by Lei Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Wei. The network helps show where Lei Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Lei Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 123 | |
| 2 | 1999 | 68 | |
| 3 | 2006 | 57 | |
| 4 | 2021 | 41 | |
| 5 | 2019 | 36 | |
| 6 | 2018 | 34 | |
| 7 | 2016 | 33 | |
| 8 | 2017 | 31 | |
| 9 | 2018 | 30 | |
| 10 | 2021 | 28 | |
| 11 | 2020 | 26 | |
| 12 | Research on the impact of new quality productivity on enterprise ESG performance Hit paper breakdown → | 2025 | 21 |
| 13 | 2023 | 21 | |
| 14 | 2024 | 19 | |
| 15 | 2018 | 18 | |
| 16 | 2015 | 16 | |
| 17 | 2022 | 15 | |
| 18 | 2020 | 14 | |
| 19 | Modulation of BCRP mediated atypical multidrug resistance phenotype by RNA interference. | 2005 | 14 |
| 20 | 2023 | 13 |
About Lei Wei
Lei Wei is a scholar working on Molecular Biology, Plant Science, Oncology, Complementary and alternative medicine and Immunology, having authored 67 papers that have together received 801 indexed citations. Recurring topics across this work include Traditional Chinese Medicine Analysis (7 papers), Pharmacological Effects of Natural Compounds (5 papers), Cytokine Signaling Pathways and Interactions (4 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), Postharvest Quality and Shelf Life Management (3 papers), Cancer therapeutics and mechanisms (3 papers), Natural product bioactivities and synthesis (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Pharmaceutical Science (91 citations), Complementary and alternative medicine (96 citations), Urology (42 citations), Pharmacology (56 citations) and Dermatology (51 citations). Lei Wei has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Min Jiang, Gang Bai, Gabrielle Williams, Jonathan C. Craig, Anna Lee, Han Zhang, Yaya Cui, Guoqiao Jiang, Asita Mukherjee and Yang Liu. Their work appears in journals such as Biomedicine & Pharmacotherapy, Frontiers in Pharmacology, Postharvest Biology and Technology, Journal of Medicinal Chemistry and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.